Literature DB >> 16210929

Predictive accuracy of the SCORE risk function for cardiovascular disease in clinical practice: a prospective evaluation of 44 649 Austrian men and women.

Hanno Ulmer1, Barbara Kollerits, Cecily Kelleher, Günter Diem, Hans Concin.   

Abstract

BACKGROUND: In 2003, a new risk function for cardiovascular risk in clinical practice was developed by the SCORE project group. The aim of this paper was to evaluate the predictive accuracy of the SCORE in a large Austrian population.
DESIGN: A prospective, multicentre, longitudinal linkage project.
METHODS: Using the 'SCORE risk function for low-risk regions', we calculated the risk of death from cardiovascular and coronary heart disease events over a 10-year period for 44 649 participants aged 40-65 years in the Vorarlberg Health Monitoring and Promotion Programme (VHM&PP). The predicted risks were compared with the 95% confidence intervals (CI) of the observed events.
RESULTS: We observed a total of 487 deaths (1.1%; 95% CI 1.0-1.2) for all cardiovascular disease within 10 years, 371 (1.8%; 95% CI 1.6-2.0) in men and 116 (0.5%; 95% CI 0.4-0.6) in women. The SCORE function overestimated cardiovascular mortality and predicted 666 (1.5%) events, 444 (2.2%) in men and 222 (0.9%) in women. Receiver operating characteristics analyses revealed area under the curve values of 0.76 (95% CI 0.74-0.79) for men and 0.78 (95% CI 0.74-0.82) for women. Multivariable analyses showed that obesity (in men only) increased levels of glucose, gamma-glutamyl transferase, triglycerides (in women only), and blue-collar job status (in women only) significantly contributed to the SCORE as additional independent risk factors.
CONCLUSION: Although the SCORE over-predicted the mortality pattern in the cohort as a whole, its predictive ability at the individual level still demonstrates a potentially widespread utility in clinical practice.

Entities:  

Mesh:

Year:  2005        PMID: 16210929     DOI: 10.1097/01.hjr.0000174791.47059.80

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  18 in total

1.  The Framingham Heart Study's impact on global risk assessment.

Authors:  Asaf Bitton; Thomas A Gaziano
Journal:  Prog Cardiovasc Dis       Date:  2010 Jul-Aug       Impact factor: 8.194

Review 2.  Assessment of cardiovascular risk.

Authors:  Marie Therese Cooney; Helen C Cooney; Alexandra Dudina; Ian M Graham
Journal:  Curr Hypertens Rep       Date:  2010-10       Impact factor: 5.369

3.  Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes: A prospective cohort study in the UK Biobank.

Authors:  Frederick K Ho; Lyn D Ferguson; Carlos A Celis-Morales; Stuart R Gray; Ewan Forrest; William Alazawi; Jason Mr Gill; Srinivasa Vittal Katikireddi; John Gf Cleland; Paul Welsh; Jill P Pell; Naveed Sattar
Journal:  EClinicalMedicine       Date:  2022-05-12

4.  Correlates and reference limits of plasma gamma-glutamyltransferase fractions from the Framingham Heart Study.

Authors:  Maria Franzini; Irene Fornaciari; Jian Rong; Martin G Larson; Claudio Passino; Michele Emdin; Aldo Paolicchi; Ramachandran S Vasan
Journal:  Clin Chim Acta       Date:  2012-12-14       Impact factor: 3.786

5.  COSEHC global vascular risk management quality improvement program: rationale and design.

Authors:  Carlos M Ferrario; Michael A Moore; William Bestermann; Chris Colby; Alex Exuzides; Debra Simmons; Sumeet Panjabi
Journal:  Vasc Health Risk Manag       Date:  2010-12-13

6.  Barriers to cardiovascular risk prevention and management in Germany--an analysis of the EURIKA study.

Authors:  Roland E Schmieder; Matthias Goebel; Peter Bramlage
Journal:  Vasc Health Risk Manag       Date:  2012-03-15

7.  Prediction of Cardiovascular Disease Mortality in a Middle Eastern Country: Performance of the Globorisk and Score Functions in Four Population-Based Cohort Studies of Iran.

Authors:  Noushin Fahimfar; Akbar Fotouhi; Mohammad Ali Mansournia; Reza Malekzadeh; Nizal Sarrafzadegan; Fereidoun Azizi; Marjan Mansourian; Sadaf G Sepanlou; Mohammad Hassan Emamian; Farzad Hadaegh; Hamidreza Roohafza; Hassan Hashemi; Hossein Poustchi; Akram Pourshams; Tahereh Samavat; Maryam Sharafkhah; Mohammad Talaei; David Van Klaveren; Ewout W Steyerberg; Davood Khalili
Journal:  Int J Health Policy Manag       Date:  2022-02-01

8.  The high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30,824 Europeans: the Copenhagen General Population Study.

Authors:  Martin B Mortensen; Shoaib Afzal; Børge G Nordestgaard; Erling Falk
Journal:  Eur Heart J       Date:  2015-06-16       Impact factor: 29.983

9.  Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study.

Authors:  Amber A W A van der Heijden; Monica M Ortegon; Louis W Niessen; Giel Nijpels; Jacqueline M Dekker
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

10.  Agreement between the SCORE and D'Agostino Scales for the classification of high cardiovascular risk in sedentary spanish patients.

Authors:  Manuel A Gómez-Marcos; Gonzalo Grandes; José A Iglesias-Valiente; Alvaro Sánchez; Imanol Montoya; Luis García-Ortiz
Journal:  Int J Environ Res Public Health       Date:  2009-11-11       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.